Omics Life Science Tools/MDx Stocks Inch up 1 Percent in March | GenomeWeb

NEW YORK (GenomeWeb) – Shares of companies in the omics life science tools and molecular diagnostics space saw a choppy March as the GenomeWeb Index inched up 1 percent month over month. 

Overall, the number of gainers in the index totaled 18, led by Sequenom, whose shares increased 13 percent in March compared to February, while 13 companies saw their share values slide in the month. Pacific Biosciences, down 7 percent month over month, had the biggest decline. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.